Global Neuroprotective Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152955
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 

Scope of the Report:

This report focuses on the Neuroprotective Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Neuroprotective Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Genervon Biopharmaceuticals (Canada)

NeuroVive Pharmaceutical (Sweden)

Ceregene (USA)

BHRPharma (Thailand)

Neuren Pharmaceuticals (Australia)

Allon therapeutics (Canada)

Bionure Inc. (USA)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cholinesterase inhibitors

NMDA receptor antagonists

Others

Market Segment by Applications, can be divided into

Alzheimer's disease

Multiple sclerosis

Others

There are 15 Chapters to deeply display the global Neuroprotective Products market.

Chapter 1, to describe Neuroprotective Products Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Neuroprotective Products, with sales, revenue, and price of Neuroprotective Products, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Neuroprotective Products, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Neuroprotective Products market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Neuroprotective Products sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Neuroprotective Products Introduction

1.2 Market Analysis by Type

1.2.1 Cholinesterase inhibitors

1.2.2 NMDA receptor antagonists

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Alzheimer's disease

1.3.2 Multiple sclerosis

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Genervon Biopharmaceuticals (Canada)

2.1.1 Business Overview

2.1.2 Neuroprotective Products Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 NeuroVive Pharmaceutical (Sweden)

2.2.1 Business Overview

2.2.2 Neuroprotective Products Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Ceregene (USA)

2.3.1 Business Overview

2.3.2 Neuroprotective Products Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Ceregene (USA) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 BHRPharma (Thailand)

2.4.1 Business Overview

2.4.2 Neuroprotective Products Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BHRPharma (Thailand) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Neuren Pharmaceuticals (Australia)

2.5.1 Business Overview

2.5.2 Neuroprotective Products Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allon therapeutics (Canada)

2.6.1 Business Overview

2.6.2 Neuroprotective Products Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allon therapeutics (Canada) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bionure Inc. (USA)

2.7.1 Business Overview

2.7.2 Neuroprotective Products Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bionure Inc. (USA) Neuroprotective Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neuroprotective Products Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Neuroprotective Products Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Neuroprotective Products Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Neuroprotective Products Manufacturer Market Share in 2017

3.3.2 Top 6 Neuroprotective Products Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Neuroprotective Products Market Analysis by Regions

4.1 Global Neuroprotective Products Sales, Revenue and Market Share by Regions

4.1.1 Global Neuroprotective Products Sales and Market Share by Regions (2013-2018)

4.1.2 Global Neuroprotective Products Revenue and Market Share by Regions (2013-2018)

4.2 North America Neuroprotective Products Sales and Growth Rate (2013-2018)

4.3 Europe Neuroprotective Products Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Neuroprotective Products Sales and Growth Rate (2013-2018)

4.5 South America Neuroprotective Products Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Neuroprotective Products Sales and Growth Rate (2013-2018)

5 North America Neuroprotective Products by Countries

5.1 North America Neuroprotective Products Sales, Revenue and Market Share by Countries

5.1.1 North America Neuroprotective Products Sales and Market Share by Countries (2013-2018)

5.1.2 North America Neuroprotective Products Revenue and Market Share by Countries (2013-2018)

5.2 United States Neuroprotective Products Sales and Growth Rate (2013-2018)

5.3 Canada Neuroprotective Products Sales and Growth Rate (2013-2018)

5.4 Mexico Neuroprotective Products Sales and Growth Rate (2013-2018)

6 Europe Neuroprotective Products by Countries

6.1 Europe Neuroprotective Products Sales, Revenue and Market Share by Countries

6.1.1 Europe Neuroprotective Products Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Neuroprotective Products Revenue and Market Share by Countries (2013-2018)

6.2 Germany Neuroprotective Products Sales and Growth Rate (2013-2018)

6.3 UK Neuroprotective Products Sales and Growth Rate (2013-2018)

6.4 France Neuroprotective Products Sales and Growth Rate (2013-2018)

6.5 Russia Neuroprotective Products Sales and Growth Rate (2013-2018)

6.6 Italy Neuroprotective Products Sales and Growth Rate (2013-2018)

7 Asia-Pacific Neuroprotective Products by Countries

7.1 Asia-Pacific Neuroprotective Products Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Neuroprotective Products Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Neuroprotective Products Revenue and Market Share by Countries (2013-2018)

7.2 China Neuroprotective Products Sales and Growth Rate (2013-2018)

7.3 Japan Neuroprotective Products Sales and Growth Rate (2013-2018)

7.4 Korea Neuroprotective Products Sales and Growth Rate (2013-2018)

7.5 India Neuroprotective Products Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Neuroprotective Products Sales and Growth Rate (2013-2018)

8 South America Neuroprotective Products by Countries

8.1 South America Neuroprotective Products Sales, Revenue and Market Share by Countries

8.1.1 South America Neuroprotective Products Sales and Market Share by Countries (2013-2018)

8.1.2 South America Neuroprotective Products Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Neuroprotective Products Sales and Growth Rate (2013-2018)

8.3 Argentina Neuroprotective Products Sales and Growth Rate (2013-2018)

8.4 Colombia Neuroprotective Products Sales and Growth Rate (2013-2018)

9 Middle East and Africa Neuroprotective Products by Countries

9.1 Middle East and Africa Neuroprotective Products Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Neuroprotective Products Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Neuroprotective Products Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Neuroprotective Products Sales and Growth Rate (2013-2018)

9.3 UAE Neuroprotective Products Sales and Growth Rate (2013-2018)

9.4 Egypt Neuroprotective Products Sales and Growth Rate (2013-2018)

9.5 Nigeria Neuroprotective Products Sales and Growth Rate (2013-2018)

9.6 South Africa Neuroprotective Products Sales and Growth Rate (2013-2018)

10 Global Neuroprotective Products Market Segment by Type

10.1 Global Neuroprotective Products Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Neuroprotective Products Sales and Market Share by Type (2013-2018)

10.1.2 Global Neuroprotective Products Revenue and Market Share by Type (2013-2018)

10.2 Cholinesterase inhibitors Sales Growth and Price

10.2.1 Global Cholinesterase inhibitors Sales Growth (2013-2018)

10.2.2 Global Cholinesterase inhibitors Price (2013-2018)

10.3 NMDA receptor antagonists Sales Growth and Price

10.3.1 Global NMDA receptor antagonists Sales Growth (2013-2018)

10.3.2 Global NMDA receptor antagonists Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Neuroprotective Products Market Segment by Application

11.1 Global Neuroprotective Products Sales Market Share by Application (2013-2018)

11.2 Alzheimer's disease Sales Growth (2013-2018)

11.3 Multiple sclerosis Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Neuroprotective Products Market Forecast (2018-2023)

12.1 Global Neuroprotective Products Sales, Revenue and Growth Rate (2018-2023)

12.2 Neuroprotective Products Market Forecast by Regions (2018-2023)

12.2.1 North America Neuroprotective Products Market Forecast (2018-2023)

12.2.2 Europe Neuroprotective Products Market Forecast (2018-2023)

12.2.3 Asia-Pacific Neuroprotective Products Market Forecast (2018-2023)

12.2.4 South America Neuroprotective Products Market Forecast (2018-2023)

12.2.5 Middle East and Africa Neuroprotective Products Market Forecast (2018-2023)

12.3 Neuroprotective Products Market Forecast by Type (2018-2023)

12.3.1 Global Neuroprotective Products Sales Forecast by Type (2018-2023)

12.3.2 Global Neuroprotective Products Market Share Forecast by Type (2018-2023)

12.4 Neuroprotective Products Market Forecast by Application (2018-2023)

12.4.1 Global Neuroprotective Products Sales Forecast by Application (2018-2023)

12.4.2 Global Neuroprotective Products Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Neuroprotective Products Picture

Table Product Specifications of Neuroprotective Products

Figure Global Sales Market Share of Neuroprotective Products by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery